PharmaShots | Incisive News in 3 Shots

Subscribe Now

SOLAR-1 trial

Novartis's Solar-1 trial BYL719 (PI3Ki- alpelisib) meets primary endpoints in advanced or mBC patients

Novartis's Solar-1 trial BYL719 (PI3Ki- alpelisib) meets primary endpoints in advanced or mBC patients

August 24, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us